Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Real Tech Holdings is a Japan-based deep tech venture capital and impact investment firm that was established in 2015 and rebranded in 2024 as UntroD. Rather than being a drug developer, it manages the Real Tech Fund franchise and invests in seed and early-stage deep tech startups across sectors including biotechnology, medical devices, energy, materials, robotics, agri-food, and other frontier technologies. The firm emphasizes hands-on support for social implementation, commercialization, regional ecosystem building, and impact-oriented investing. It operates domestically in Japan and internationally through Southeast Asia-focused activities, and works with corporate, institutional, and academic networks to source and scale portfolio companies. For a biotech analyst, the key point is that this is an investor with healthcare and biotech exposure, not a healthcare operating company with its own therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Real Tech Holdings.